JAGX

Jaguar Health, Inc.

Halal Rating :
Comfortable
Last Price $0.96 Last updated:
Market Cap $10.54m
7D Change 2.34%
1 Year Change 460.93%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NASDAQ
Next Earnings Date Nov. 12, 2024

Jaguar Health, Inc. is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. The company's key product is Mytesi® (crofelemer), an FDA-approved plant-based medicine indicated for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $3.11m $10.21m - $-162000.0 0.00% 1.59%
June 30, 2024 $2.72m $9.81m - $-108000.0 0.00% 1.10%
March 31, 2024 $2.35m $9.93m - $-634000.0 0.00% 6.38%

Company Impact

Help us evaluate Jaguar Health, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates